Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00897026 · ClinicalTrials.gov registry record
Studying Tissue Samples From Women Who Underwent Chemotherapy for Lymph Node-Positive Stage II or Stage IIIA Breast Cancer on Clinical Trial CLB-9741 or CLB-9344
A clinical trial, sponsored by Alliance for Clinical Trials in Oncology.
- Completed
- Registry status
- 1,195
- Enrollment target
NCT00897026: Completed study, sponsored by Alliance for Clinical Trials in Oncology.
NCT00897026 is a clinical trial that has completed, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 1,195 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00897026 has completed, sponsored by Alliance for Clinical Trials in Oncology.
- COMPLETED
- Registry status
- 1,195 participants
- Enrollment target
Study Summary
RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors plan the best treatment. PURPOSE: This research study is looking at tissue samples from women who underwent chemotherapy for lymph node-positive stage II or stage IIIA breast cancer.
Interventions
- DRUG cyclophosphamide
- OTHER immunohistochemistry staining method
- DRUG paclitaxel
- DRUG doxorubicin hydrochloride
- GENETIC fluorescence in situ hybridization
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,195 participants |
| Start Date | 2008-07 |
| Est. Completion | 2012-04-27 |
What the finished NCT00897026 record still lists
NCT00897026 is an observational study that tracks outcomes without assigning an intervention. Its 1,195 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 5 interventions - of which cyclophosphamide is the first listed.
NCT00897026 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00897026 about?
NCT00897026 is a clinical study titled "Studying Tissue Samples From Women Who Underwent Chemotherapy for Lymph Node-Positive Stage II or Stage IIIA Breast Cancer on Clinical Trial CLB-9741 or CLB-9344". RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors plan the best treatment. PURPOSE: This research study is looking at tissue samples ...
What is the current status of trial NCT00897026?
This trial is currently completed. The enrollment target is 1,195 participants. The study started on 2008-07. Estimated completion is 2012-04-27.
What interventions are being tested in trial NCT00897026?
The interventions under investigation include: cyclophosphamide (DRUG), immunohistochemistry staining method (OTHER), paclitaxel (DRUG), doxorubicin hydrochloride (DRUG), fluorescence in situ hybridization (GENETIC).
Who is sponsoring clinical trial NCT00897026?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07177339 · 1,196 participants · Phase 3
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- NCT00001987 · 1,200 participants
Genetic Studies of Insulin and Diabetes
- NCT00477100 · 1,200 participants
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
- NCT01209000 · 1,200 participants
Nephrotic Syndrome Study Network
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia